Clinical trial · Observational
Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is being done to see if the Nova Creatinine Meter can give a correct measure of creatinine (a blood test used to measure kidney function) when the blood is taken from a capillary (smallest type of blood vessels). The Nova Creatinine Meter is a hand held device that can be used in a clinic to measure creatinine in about 50 seconds. Current laboratory creatinine testing can take up to an hour. Since chemotherapy patients need to have their creatinine measured prior to treatment, this meter could make testing easier and faster.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| hand-held POC creatinine analyzer-blood test | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- Patients having a creatinine drawn
- interventionNames
- Other: hand-held POC creatinine analyzer-blood test
Primary outcomes (1)
- measure
- The primary outcomes would be, reduced wait time and increased patient satisfaction.
- timeFrame
- conclusion of the study
Secondary outcomes (1)
- measure
- reduced blood loss
- timeFrame
- conclusion of the study
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Written Informed Consent * Must have a creatinine \> or = to than 3.5 mg/dl Exclusion Criteria: * Patients who are less than 18 years of age
References
Publications (0)
Data not yet available